a Low-residue Diet for Bowel Preparation

NCT03943758 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 589

Last updated 2022-01-11

No results posted yet for this study

Summary

Previous researches demonstrated that a prepackaged low-residue diet (LRD) could achieve better bowel preparation quality compared with a self-prepared LRD. However, up to now, there has been no widely acceptable standard of LRD for bowel preparation. Moreover, these prepackaged LRD adopted in previous studies mainly consisted of traditional foods without further processing. Recently, a prepackaged LRD for Special Medical Purpose was specifically designed for bowel preparation. This trail was to compare the impact of the prepackaged LRD on bowel preparation for colonoscopy with self-prepared LRD by patients.

Conditions

  • Colon Polyp
  • Colorectal Adenoma

Interventions

DIETARY_SUPPLEMENT

Prepackaged Low-residue diet

Subjects in the prepackaged Low-residue diet group were given 6 packs (60g/pack) pre-packaged formula LRD and asked to use the formula according to individual needs prior to colonoscopy.

DIETARY_SUPPLEMENT

Self-prepared Low-residue diet

Subjects in the self-prepared Low-residue diet group were instructed to follow and prepare an Low-residue diet in the day prior to colonoscopy.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Jinan Military General Hospital

    collaborator OTHER
  • Wuhan TongJi Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhaoshen Li, M.D. · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2020-12-10
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03943758 on ClinicalTrials.gov